Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

761
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

628
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
628
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

1.0K
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fluoroquinolones for TB preventive treatment of contacts exposed to persons with multidrug-resistant TB: a systematic review and meta-analysis.

IJTLD open·2026
Same author

Mental health management in the context of TB care in the WHO European Region: a consensus statement.

IJTLD open·2026
Same author

Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocol.

IJTLD open·2026
Same author

Clinical best practices for caring for people with expanded resistance to newer TB drugs.

IJTLD open·2025
Same author

TB screening of children from Ukraine in Germany.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.

IJTLD open·2025

Related Experiment Video

Updated: Mar 26, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.4K

[Standard therapy of tuberculosis].

R Otto-Knapp1,2, K Schenkel3, T Bauer3,4

  • 1Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK e.V.), Haus Q, Walterhöferstr. 11, 14165, Berlin, Deutschland. rotto-knapp@dzk-tuberkulose.de.

Der Internist
|February 10, 2016
PubMed
Summary

Standard tuberculosis therapy needs adjustments due to increased migration. New guidelines are in development to address rising tuberculosis cases and ensure effective diagnosis and treatment for all patients.

Keywords:
Adjuvant TherapyDrug monitoringEpidemiology, tuberculosisMedication adherencePatient education

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Related Experiment Videos

Last Updated: Mar 26, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.4K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The current standard short-course tuberculosis therapy, established in the 1960s-1980s, requires adaptation to regional epidemiology and national health system specifics.
  • Increased migration from high-tuberculosis-incidence countries into Germany is projected to raise the number of tuberculosis cases.
  • This rise in cases necessitates greater contact with tuberculosis patients, even in outpatient settings, highlighting the need for updated treatment protocols.

Purpose of the Study:

  • To summarize practical evidence for diagnosing and treating uncomplicated tuberculosis.
  • To address the challenges posed by an expected increase in tuberculosis cases.
  • To provide interim guidance before the release of comprehensive S2k guidelines for tuberculosis treatment.

Main Methods:

  • Review of existing studies and recommendations from the German Central Committee against Tuberculosis (DZK).
  • Analysis of epidemiological trends related to migration and tuberculosis incidence.
  • Synthesis of practical evidence for diagnosis and treatment of uncomplicated tuberculosis.

Main Results:

  • The established four-drug combination therapy remains the global standard but requires localized adjustments.
  • An increase in tuberculosis cases in Germany is anticipated due to migration.
  • Current recommendations by the DZK have been updated to reflect recent developments.

Conclusions:

  • Regional specificities and migration patterns necessitate tailored tuberculosis treatment strategies.
  • The development of new S2k guidelines by the AWMF is crucial for comprehensive tuberculosis management.
  • This document provides essential practical information for managing uncomplicated tuberculosis in light of evolving public health challenges.